Conjugates of antibody and duoarmycin derivatives as antitumor agents

Details for Australian Patent Application No. 2005259487 (hide)

Owner Novartis AG The Scripps Research Institute

Inventors Boger, Dale, L.; Wirsching, Peter; Janda, Kim, D.

Agent Davies Collison Cave

Pub. Number AU-A-2005259487

PCT Pub. Number WO2006/002895

Priority 60/584,226 30.06.04 US

Filing date 29 June 2005

Wipo publication date 12 January 2006

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 487/10 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2006/002895 Priority application(s): WO2006/002895

1 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005259488-Method for increasing the susceptibility of peptide deformylase inhibitors by using efflux pump inhibitors

2005259481-Improved adjuvant therapy of G250-expressing tumors